Hey Suckii, ‘ol diamond, I would have liked to thumb you up for your enthusiasm but partly disagree with your outlook.
I have little expections of Admedus ‘doing’ any deal for the immunotherapies division and retaining ANYWHERE near a 51% interest there after.
If I am wrong you have my permission to rub my nose in it IF I am wrong.
I would say to you Suckii, put aside AI and fully concentrate on the Ultimate prize .... the successful launch of the Adapt Range in the medium/long term future, put AI to rest, a ‘tattslotto’ stoke of success a windfall, Medical Division to be spun off in the long term future once Adapt platform tech ‘kickin’ Ass’.
Would like to see see this company as a sole entity that is entirely Adapt focused, this company, (if not taken over in the distant future) and be the ‘go to’ company for surgeons around the Globe.
At this point in time, with due patience, I am quietly confident, more so if we are, by Xmas, trading at the 40 cent range up, if at the current sp I will be wondering WHY!
My journey with Admedus, briefly, can be summed up as follows: Naively super confident/postive, Especially so with the AI, as time went by I became way more pragmatic and lost the ‘respect’ of my fellow posters by posting those pragmatic/contrary views, I have no regrets for that.
Now at the stage where I am quietly confident, with I hope due justification to be so, utterly believe if WP cannot pull this off then it wasn’t meant to happen.
I might even be able to ‘put up’ with stonemasons ‘I told you so’ ...... might!, lol
AHZ Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
(20min delay)